The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC
Authors:
Open Access
- 11 June 2021
- journal article
- research article
- Published by Springer Nature in Molecular Cancer
- Vol. 20 (1) , 1-21
Abstract
Background: Recent studies have revealed that circular RNAs (circRNAs) play significant roles in the occurrence and development of many kinds of cancers including breast cancer (BC). However, the potential functions of most circRNAs and the molecular mechanisms underlying progression of BC remain elusive. Method: Here, Circular RNA microarray was executed in 4 pairs of breast cancer tissues and para-cancer tissues. The expression and prognostic significance of circACTN4 in BC cells and tissues were determined by qRT-PCR and in situ hybridization. Gain-and loss-of-function experiments were implemented to observe the impacts of circACTN4 on the growth, invasion, and metastasis of BC cells in vitro and in vivo. Mechanistically, chromatin immunoprecipitation, luciferase reporter, RNA pulldown, mass spectrum, RNA immunoprecipitation, fluorescence in situ hybridization and co-immunoprecipitation assays were executed. Results: CircACTN4 was significantly upregulated in breast cancer tissues and cells, its expression was correlated with clinical stage and poor prognosis of patients with BC. Ectopic expression of circACTN4 strikingly facilitated the growth, invasion, and metastasis of breast cancer cells in vitro and in vivo. Whereas knockdown of circACTN4 revealed opposite roles. CircACTN4 was mainly distributed in the nucleus. Further mechanistic research proved that circACTN4 could competitively bind to far upstream element binding protein 1 (FUBP1) to prevent the combination between FUBP1 and FIR, thereby activating MYC transcription and facilitating tumor progression of breast cancer. Furthermore, we found that upstream transcription factor 2 (USF2) might promote the biogenesis of circACTN4. Conclusion: Our findings uncover a pivotal mechanism that circACTN4 mediated by USF2 might interact with FUBP1 to promote the occurrence and development of breast cancer via enhancing the expression of MYC. CircACTN4 could be a novel potential target for diagnosis and treatment of breast cancer.Keywords
Funding Information
- National Natural Science Foundation of China (No. 81672536)
- Chongqing Municipal Education Commission (No. KJZD-K202000405)
- Chongqing Medical University (No. BJRC201918)
This publication has 47 references indexed in Scilit:
- C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signalingJournal of Molecular Medicine, 2016
- c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cellsCell Cycle, 2016
- Overexpression of c-myc is associated with adverse clinical features and worse overall survival in multiple myelomaLeukemia & Lymphoma, 2016
- Far upstream element-binding protein 1 (FUBP1) is a potential c-Myc regulator in esophageal squamous cell carcinoma (ESCC) and its expression promotes ESCC progressionTumor Biology, 2015
- Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progressionCell Death & Disease, 2015
- Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c‐Myc and cell proliferationMolecular Carcinogenesis, 2013
- Far Upstream Element-Binding Protein 1 (FUBP1) is Overexpressed in Human Gastric Cancer Tissue Compared to Non-Cancerous TissueOncology Research and Treatment, 2013
- Far upstream element binding protein 1: a commander of transcription, translation and beyondOncogene, 2012
- Mutations in CIC and FUBP1 Contribute to Human OligodendrogliomaScience, 2011
- Quantitative Characterization of the Interactions amongc-mycTranscriptional Regulators FUSE, FBP, and FIRBiochemistry, 2010